NEXGEL, Inc. (NXGL) は上場企業です ヘルスケア セクターの Medical - Instruments & Supplies 業界で事業展開. 本社所在地は Langhorne, PA, アメリカ. 現CEOは Adam R. Levy.
NXGL を有する IPO日 2021-12-22, 19 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $6.34M.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
